8:45am ET
Health and Healthcare
Biotech Short Sellers Focus on a Couple Favorites
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
BIIB Coverage Page 8
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and Zynga.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Alphabet, Apple, AT&T, Biogen, CSX, Dow, Facebook, Penn, McDonald’s, Microsoft, Tesla and More
Thursday's top analyst upgrades, downgrades and initiations included Alphabet, Apple, AT&T, Biogen, CSX, Dow, Facebook, McDonald's, Microsoft and Tesla.
8:45am ET
Health and Healthcare
Short Sellers Wary on Major Biotechs
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
1:55pm ET
Health and Healthcare
Why Biogen Could Become the King of Alzheimer’s Disease Treatment
If there is one group that can produce stock gains regardless of the daily market activities, that would be biotechnology and emerging pharmaceuticals. Coming up with a new approach or new way…
Jon C. Ogg 11:30am ET
Health and Healthcare
What to Expect From Pfizer, Biogen and Allergan Earnings Tuesday Morning
These three health care companies included are expected to report their earnings on Tuesday morning.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Apple, Biogen, Chewy, Comcast, Deere, Facebook, Intel, SolarEdge, Wynn and More
Monday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Apple, Biogen, Chewy, Comcast, Deere, Facebook, Intel, SolarEdge Technologies and Wynn Resorts.
7:10am ET
Investing
Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and General Electric.
8:40am ET
Health and Healthcare
Major Biotechs Have Short Sellers Excited
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
8:40am ET
Health and Healthcare
Major Biotechs See Rising Short Interest
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More
The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap and Wayfair.
9:10am ET
Health and Healthcare
Major Biotechs See a Rising Tide in Short Interest
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: ADT, Altria, Biogen, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku, Schwab, Wells Fargo and More
Monday's top analyst upgrades, downgrades and initiations included ADT, Altria, Biogen, Charles Schwab, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku and Wells Fargo.
10:40am ET
Health and Healthcare
Major Biopharma Catalysts on the December FDA Calendar
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of December.